Several large-scale cardiovascular outcome trials (including LEADER, SUSTAIN-6, and REWIND) have shown that certain GLP-1 receptor agonists liraglutide, semaglutide, and dulaglutide reduce the risk of major adverse cardiovascular events such as heart attack, stroke, and cardiovascular death in people with established cardiovascular disease or multiple cardiovascular risk factors
Built for performance: unser L-Carnitine
Mller TD, Finan B, Clemmensen C, et al
PMID: 13 ChenJ.LiT.ZhouN.HeY.ZhongJ.MaC.et al
Immune System Support By reducing oxidative stress, Glutathione enhances immune function, helping your body better resist infections and recover from illness
Ideal For: People who have trouble remembering a daily pill or who cannot wait 30 minutes in the morning to eat or drink coffee